Brief: Newbury Pharmaceuticals Gets Sales Order Valued At SEK 8.8 Mln
Feb 22 (Reuters) - Newbury Pharmaceuticals AB
NEWBRY.ST :
* NEWBURY PHARMACEUTICALS RECEIVES INTERNATIONAL SALES ORDER
VALUED AT 8.8 MILLION SEK
* VALUE OF THIS ORDER IS APPROXIMATELY 8.8 MILLION SEK
Source text for Eikon: ID:nMFN8f0wLJ
Further company coverage: NEWBRY.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com;))
Recent news on Newbury Pharmaceuticals AB
See all newsBrief: Newbury Secures Hospital Portfolio Rights In Iraq
Brief: Newbury Signs Licence And Supply Deal For Guanfacine
Brief: Newbury Pharmaceuticals Gets Approval for Tofacitinib Newbury
Brief: Newbury Pharmaceuticals Secures Generic Approval For Dalbavancin Newbury
Brief: Newbury Pharmaceuticals Reports Q3 EBITDA Of SEK -4 Mln